 for patients treated medically; aggregate risk reduction, 53%;
95% conÔ¨Ådence interval [CI], 22%-72%).2 The ACAS recommended CEA for patients aged <80 years as long as
the expected combined stroke and mortality rate for
the individual surgeon was not >3%. The conclusions
from the ACAS were supported by a subsequent larger
RCT that had randomized 3120 patients to immediate
CEA vs medical therapy.5